Hidemaru Yamaguchi
Stock Analyst at Citi
(2.37)
# 3,074
Out of 5,078 analysts
65
Total ratings
53.5%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4503 Astellas Pharma Inc. | Reiterated: Hold | ¥2,400 → ¥2,470 | ¥2,512 | -1.67% | 4 | Aug 7, 2026 | |
| TYO: 4587 PeptiDream Inc. | Reiterated: Hold | ¥1,600 → ¥1,100 | ¥1,060 | +3.82% | 3 | Jul 22, 2026 | |
| TYO: 4592 SanBio Company Limited | Upgraded: Buy | ¥1,800 | ¥924 | +94.81% | 1 | Jul 16, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Reiterated: Sell | ¥1,260 → ¥1,500 | ¥1,854 | -19.07% | 5 | May 25, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | ¥2,981 | -6.06% | 1 | Apr 3, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | ¥2,413 | -17.10% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Reiterated: Buy | ¥2,600 → ¥2,800 | ¥1,901 | +47.33% | 6 | Feb 9, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Reiterated: Hold | ¥600 → ¥670 | ¥523 | +28.11% | 4 | Feb 5, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥5,800 → ¥4,900 | ¥2,818 | +73.91% | 6 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Reiterated: Buy | ¥1,100 → ¥1,400 | ¥1,343 | +4.24% | 5 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,900 → ¥6,200 | ¥5,076 | n/a | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,800 → ¥3,900 | ¥2,399 | n/a | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,200 → ¥3,500 | ¥3,698 | n/a | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,750 | ¥2,499 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥10,400 → ¥10,500 | ¥12,455 | n/a | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,100 → ¥4,600 | ¥3,432 | n/a | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥2,600 | ¥1,734 | n/a | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥4,200 → ¥3,500 | ¥3,565 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥960 | ¥1,281 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥2,410 | ¥3,206 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | ¥2,006 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥12,000 | ¥6,795 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥3,100 → ¥2,800 | ¥3,036 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,300 | ¥1,939 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $35.74 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $23.80 | n/a | 1 | Nov 18, 2009 |
Astellas Pharma Inc.
Aug 7, 2026
Reiterated: Hold
Price Target: ¥2,400 → ¥2,470
Current: ¥2,512
Upside: -1.67%
PeptiDream Inc.
Jul 22, 2026
Reiterated: Hold
Price Target: ¥1,600 → ¥1,100
Current: ¥1,060
Upside: +3.82%
SanBio Company Limited
Jul 16, 2026
Upgraded: Buy
Price Target: ¥1,800
Current: ¥924
Upside: +94.81%
Sumitomo Pharma Co., Ltd.
May 25, 2026
Reiterated: Sell
Price Target: ¥1,260 → ¥1,500
Current: ¥1,854
Upside: -19.07%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: ¥2,981
Upside: -6.06%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: ¥2,413
Upside: -17.10%
M3, Inc.
Feb 9, 2026
Reiterated: Buy
Price Target: ¥2,600 → ¥2,800
Current: ¥1,901
Upside: +47.33%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Reiterated: Hold
Price Target: ¥600 → ¥670
Current: ¥523
Upside: +28.11%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Reiterated: Buy
Price Target: ¥5,800 → ¥4,900
Current: ¥2,818
Upside: +73.91%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Reiterated: Buy
Price Target: ¥1,100 → ¥1,400
Current: ¥1,343
Upside: +4.24%
Sep 12, 2025
Reiterated: Buy
Price Target: ¥5,900 → ¥6,200
Current: ¥5,076
Upside: n/a
Aug 29, 2025
Reiterated: Buy
Price Target: ¥3,800 → ¥3,900
Current: ¥2,399
Upside: n/a
Aug 29, 2025
Reiterated: Buy
Price Target: ¥3,200 → ¥3,500
Current: ¥3,698
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: ¥1,750
Current: ¥2,499
Upside: n/a
Aug 27, 2025
Reiterated: Buy
Price Target: ¥10,400 → ¥10,500
Current: ¥12,455
Upside: n/a
Aug 26, 2025
Reiterated: Buy
Price Target: ¥5,100 → ¥4,600
Current: ¥3,432
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: ¥2,600
Current: ¥1,734
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: ¥4,200 → ¥3,500
Current: ¥3,565
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: ¥960
Current: ¥1,281
Upside: n/a
Jun 26, 2025
Reiterated: Hold
Price Target: ¥2,410
Current: ¥3,206
Upside: n/a
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: ¥2,006
Upside: n/a
May 27, 2025
Reiterated: Buy
Price Target: ¥12,000
Current: ¥6,795
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: ¥3,100 → ¥2,800
Current: ¥3,036
Upside: n/a
Nov 26, 2024
Reiterated: Hold
Price Target: ¥3,300
Current: ¥1,939
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $35.74
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $23.80
Upside: n/a